| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/20/2000 | WO2000004196A3 Cis acting nucleic acid elements and methods of use |
| 04/20/2000 | WO2000003687A3 Potassium channel polypeptide and polynucleotide compositions |
| 04/20/2000 | WO2000002999A3 Medium and matrix for long-term proliferation of cells |
| 04/20/2000 | WO2000000638A3 Tagging of rna amplicons generated by transcription-based amplification |
| 04/20/2000 | WO2000000622A3 Human oxidoreductase proteins |
| 04/20/2000 | WO1999067407A3 Transgenetic non-human animal which comprises an inactive peg3 gene, and the use thereof |
| 04/20/2000 | WO1999066065A3 Proteasomal activity |
| 04/20/2000 | WO1999064626A8 Probes used for genetic profiling |
| 04/20/2000 | WO1999061888A8 Microfabricated cell sorter |
| 04/20/2000 | WO1999061653A3 Light-mediated regional analysis of biologic material |
| 04/20/2000 | WO1999061469A3 Prostate growth-associated membrane proteins |
| 04/20/2000 | WO1999060986A3 Apoptosis modulators that interact with the huntington's disease gene |
| 04/20/2000 | WO1999058947A9 Modulation of molecular interaction sites on rna and other biomolecules |
| 04/20/2000 | WO1999058665A3 Isolation and use of fetal urogenital sinus expressed sequences |
| 04/20/2000 | WO1999054463A3 Human k+ ion channel and therapeutic applications thereof |
| 04/20/2000 | WO1999053062A3 Isolated sh3 genes associated with myeloproliferative disorders and leukemia, and uses thereof |
| 04/20/2000 | WO1999047696A3 Assays for detecting substances with an anti-hiv action |
| 04/20/2000 | DE19847690A1 Diagnosing sepsis and severe infections, useful for assessing severity and progress of treatment, by measuring content of peptide prohormone or their derived fragments |
| 04/20/2000 | DE19846499A1 Production of microorganisms that overproduce pantothenic acid, useful as vitamin in e.g. foods or medicines, by overexpressing sequences that encode ketopantothenate reductase |
| 04/20/2000 | DE19846148A1 Verfahren und Testbesteck zur Beurteilung der oxidativen Modifikation proteinhaltiger Stoffe mittels Messung ihrer antiradikalen Aktivität Method and test kit for assessing the oxidative modification of protein substances by measuring their anti-radical activity |
| 04/20/2000 | DE19846077A1 Identifying trypanosome-binding nucleic acids and related peptides, useful for treatment and diagnosis of trypanosomal infections comprises treating a nucleic acid with trypanosomes |
| 04/20/2000 | DE19758598A1 Test for proliferation of microorganisms, viruses and/or cells, e.g. on biomedical materials, pharmaceutical products, coatings or detergents, comprises using multiple samples of predetermined geometry and size |
| 04/20/2000 | CA2675802A1 Use of an immunoglobulin-producing cell line to gererate diversity in a gene or gene product |
| 04/20/2000 | CA2450824A1 Methods and compositions for inhibiting neoplastic cell growth |
| 04/20/2000 | CA2356613A1 Improved hybridisation assay in which excess probe is destroyed |
| 04/20/2000 | CA2348003A1 Novel interferon stimulated and repressed genes |
| 04/20/2000 | CA2347653A1 Novel cell signaling polypeptides and nucleic acids |
| 04/20/2000 | CA2347247A1 Genes for assessing cardiovascular status and compositions for use thereof |
| 04/20/2000 | CA2347113A1 Human ankyrin family protein |
| 04/20/2000 | CA2346877A1 Specific genetic modification of the activity of trehalose-6-phosphate synthase and expression in a homologous or heterologous environment |
| 04/20/2000 | CA2346775A1 Protein kinase homologs |
| 04/20/2000 | CA2346743A1 Metabolic selection methods |
| 04/20/2000 | CA2346713A1 Neisseria genomic sequences and methods of their use |
| 04/20/2000 | CA2346364A1 Method for determining transcription factor activity and its technical uses |
| 04/20/2000 | CA2346122A1 Stabilized bioactive peptides and methods of identification, synthesis and use |
| 04/20/2000 | CA2346036A1 Methods for regulating bone formation |
| 04/20/2000 | CA2346031A1 Methods for stimulating bone formation |
| 04/20/2000 | CA2346008A1 G-protein-coupled receptor-like proteins, polynucleotides encoded by them, and methods of using same |
| 04/20/2000 | CA2346006A1 Delta 6 fatty acid desaturase |
| 04/20/2000 | CA2345885A1 Bone morphogenic protein-induced genes and polypeptides, and their use in diagnostic and therapeutic methods |
| 04/20/2000 | CA2345438A1 Microarray system and process for performing biochemical reactions |
| 04/20/2000 | CA2344978A1 Genes, proteins and biallelic markers related to central nervous system disease |
| 04/20/2000 | CA2344853A1 Assay for disease related conformation of a protein |
| 04/20/2000 | CA2342314A1 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 04/20/2000 | CA2314426A1 Multiple fusion probes |
| 04/20/2000 | CA2314004A1 Matrix-remodeling genes |
| 04/19/2000 | EP0994193A1 Method for the detection of organisms based on their nucleic acid composition |
| 04/19/2000 | EP0993469A1 COMPOUNDS ENCODING THE PROTECTIVE M-LIKE PROTEIN OF $i(STREPTOCOCCUS EQUI) AND ASSAYS THEREFOR |
| 04/19/2000 | EP0807186B1 Methods for the isothermal amplification of nucleic acid molecules |
| 04/19/2000 | EP0789711B1 Identification of the p21-waf1 -pcna interaction site and therapeutic applications thereof |
| 04/19/2000 | EP0785941B1 Porphyrin labeling of polynucleotides |
| 04/19/2000 | EP0598840B1 Human calcium channel compositions and methods |
| 04/19/2000 | EP0586520B1 Backbone modified oligonucleotide analogs |
| 04/19/2000 | CN1251138A Method for identifying genetic marker loci associated with trait loci |
| 04/19/2000 | CN1051559C Novel aminooligosaccharide derivative and process for preparing same |
| 04/18/2000 | US6051719 Dibenzorhodamine dyes |
| 04/18/2000 | US6051698 Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes |
| 04/18/2000 | US6051697 Chemokine expressed in eosinophils |
| 04/18/2000 | US6051696 Process for typing of HCV isolates |
| 04/18/2000 | US6051691 Amino acid sequence of protein; for screening bactericides and bacteristats especially targeted to streptococci |
| 04/18/2000 | US6051636 Denaturing solvent for electrophoresis of nucleic acids comprising an entangled polymer formed by a linear polymer; and a denaturant selected from n-alkyl pyrrolidinone, delta-valerolactam, n-methylcaprolactam and lactone |
| 04/18/2000 | US6051417 Prostate cancer drug screening using hKLK2 enhancer |
| 04/18/2000 | US6051416 Methods for producing enhanced antigenic Helicobacter sp. |
| 04/18/2000 | US6051400 An expression system comprising of a polynucleotide encoding a protein; therapy and diagnosis of kidney diseases, cardiovascular disorders, strokes, alzheimer's disease; anticarcinogenic agents and antiinflammatory agents |
| 04/18/2000 | US6051398 Nucleic acids encoding CR3 polypeptide, vector and transformed cell thereof, and expression thereof |
| 04/18/2000 | US6051396 Method for producing retinoblastoma gene protein products |
| 04/18/2000 | US6051394 Detection of microorganisms |
| 04/18/2000 | US6051391 Detection of microbial metabolites |
| 04/18/2000 | US6051390 Indirectly quantitating an enzyme by administering an amount of an inhibitor high molecular weight complex or an inhibitor high molecular weight conjugate that binds to enzyme; measure change in ciruclating concentration of conjugate in blood |
| 04/18/2000 | US6051389 An apparatus measuring concentration or activity of an analyte in test fluid; comprising of an immobilized enzyme cross-linked to macromolecule in the presence of competitive inhibitor; stabilizing enzymatic activity of sensor |
| 04/18/2000 | US6051386 Introducing a stimulant to test cells of a pigment cell line expressing exogenous cell surface receptor to set an initial state of pigment disposition, contacting with test chemical; change in pigment disposition indicates an agonist |
| 04/18/2000 | US6051382 Process for recognizing the risk of becoming ill after an arthropod bite |
| 04/18/2000 | US6051381 Escherichia host cell containing a fusion protein, a dna binding domain, protein interacting domain, and a reporter gene linked to a promoter; used as a yeast two-hybrid system; interaction cloning, mapping/analyzing protein interactions |
| 04/18/2000 | US6051380 Hybridizing dna in an electrophoresis system using a low conductivity, zwitterionic buffer; transporting dna toward a microlocation where ph of buffer is below the isoelectric point, enhancing hybridization of dna to probe |
| 04/18/2000 | US6051379 Oligonucleotides capable of detecting mutations in a tumor suppressor gene at specific locations using an allele specific detection assay; for detection possible development of breast and ovarian cancer |
| 04/18/2000 | US6051378 Methods of screening nucleic acids using mass spectrometry |
| 04/18/2000 | US6051377 Multiplex assay for nucleic acids employing transponders |
| 04/18/2000 | US6051376 Uses of mda-6 |
| 04/18/2000 | US6051375 Glycoprotein B of the RFHV/KSHV subfamily of herpes viruses |
| 04/18/2000 | US6051374 Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use |
| 04/18/2000 | US6051373 Methods for screening for inhibitors of the transcription-enhancing activity of the X protein of hepatitis B virus |
| 04/18/2000 | US6051221 BRK protein tyrosine kinase and encoding nucleic acid |
| 04/18/2000 | CA2156176C Dna polymerases with enhanced thermostability and enhanced length and efficiency of primer extension |
| 04/18/2000 | CA2092195C Retroviral packaging cell line |
| 04/16/2000 | CA2284857A1 G protein coupled receptor a4 |
| 04/15/2000 | CA2284853A1 Methods for identifying compounds for inhibition of neoplastic lesions, and pharmaceutical compositions containing such compounds |
| 04/13/2000 | WO2000020872A1 Method to determine a predisposition to leptin treatment |
| 04/13/2000 | WO2000020870A1 Characterising polypeptides through cleavage and mass spectrometry |
| 04/13/2000 | WO2000020868A1 Screen for risk for gastric adenocarcinoma |
| 04/13/2000 | WO2000020867A1 A novel ret-independent signaling pathway for gdnf |
| 04/13/2000 | WO2000020863A1 Toxin detector |
| 04/13/2000 | WO2000020853A1 Multi-conditional sscp (sscp5): a rapid method for mutation scanning with virtually 100% sensitivity |
| 04/13/2000 | WO2000020852A1 Conductive organic sensors, arrays and methods of use |
| 04/13/2000 | WO2000020835A2 Thromboplastin reagents and methods for preparing and using such reagents |
| 04/13/2000 | WO2000020644A1 Molecular diagnostics for galactosemia |
| 04/13/2000 | WO2000020643A1 Reverse displacement assay for detection of nucleic acid sequences |
| 04/13/2000 | WO2000020641A1 Tissue analysis and kits therefor |
| 04/13/2000 | WO2000020640A1 A novel method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers |
| 04/13/2000 | WO2000020639A1 Enzymatic synthesis of oligonucleotide tags |
| 04/13/2000 | WO2000020638A2 Methods and compositions for the diagnosis and therapy of prostate cancer |